Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2023-04-11 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
湖南启元律师事务所关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券的补充法律意见书（二）.doc
Capital/Financing Update Classification · 95% confidence The document is a detailed legal opinion and supplementary legal opinion related to the issuance of convertible corporate bonds by Yifeng Pharmacy Chain Co., Ltd. It includes extensive legal analysis, regulatory references, contract details, and compliance with securities regulations. The document references specific regulatory feedback from the China Securities Regulatory Commission and Shanghai Stock Exchange, and discusses the legal compliance of the bond issuance process. It is not a financial report, earnings release, or management discussion, but a legal opinion supporting a capital raising activity. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it relates to the issuance of convertible bonds and associated legal opinions for that financing event.
2023-04-11 Chinese
中信证券股份有限公司关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券申请文件的审核问询函的回复报告.docx
Capital/Financing Update Classification · 95% confidence The document is a detailed reply report to an inquiry letter from the Shanghai Stock Exchange regarding the application for issuance of convertible corporate bonds by Yifeng Pharmacy Chain Co., Ltd. It includes extensive information about the company's online business operations, contract details, compliance with industry practices, revenue breakdowns, and required licenses and permits. The document is a formal regulatory response related to a financing activity (issuance of convertible bonds) and contains detailed operational and compliance information but does not present itself as a financial report like an annual or interim report. It is not a simple announcement or a certification but a substantive reply to a regulatory inquiry. Given the context and content, this document fits best under the category of Capital/Financing Update (CAP), as it relates to the company's financing activities and regulatory review thereof.
2023-04-11 Chinese
益丰药房关于向不特定对象发行可转换公司债券申请文件的审核问询函的回复公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding its response to an inquiry letter from the Shanghai Stock Exchange about its application to issue convertible bonds to unspecified investors. It mentions the review process by the exchange and the China Securities Regulatory Commission, and that the issuance is subject to approval. The document is short (792 characters) and primarily serves as a disclosure of the company's reply to a regulatory inquiry rather than the issuance itself or detailed financial data. This fits the category of a Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes, specifically the issuance of convertible bonds.
2023-04-11 Chinese
天健会计师事务所（特殊普通合伙）关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券申请文件的问询函专项说明.docx
Regulatory Filings
2023-04-11 Chinese
益丰药房关于归还暂时用于补充流动资金的可转换公司债券募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the repayment of temporarily used convertible bond funds that were used to supplement working capital. It details amounts used, repaid, and future repayment plans. The content focuses on capital usage and financing activities related to convertible bonds and fundraising proceeds. It does not contain financial statements or detailed financial results, nor is it a report or presentation. The document is a specific update on capital/financing activities, fitting the Capital/Financing Update (CAP) category.
2023-03-31 Chinese
益丰药房关于收到上海证券交易所《关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券申请文件的审核问询函》的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding receipt of an inquiry letter from the Shanghai Stock Exchange about the company's application to issue convertible bonds to unspecified investors. It discusses the review process, the need for regulatory approval, and the company's commitment to disclose further information. The document is short (829 characters) and serves as an update on a financing activity rather than a full report or detailed financial data. It does not contain financial statements or detailed analysis but is clearly related to capital raising and financing activities. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2023-03-30 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.